About AMPE

Ampio Pharmaceuticals, Inc. is a clinical trial stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. We are developing compounds that decrease inflammation by (i) inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; (ii) activating specific phosphatase or depletion of the available phosphate needed for the inflammation process; and (iii) decreasing vascular permeability.
Primary Exchange: AMEX
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

AMPE is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
URTY ProShares UltraPro Russell2000 105.8 M 1.05784E+08 2,016 2016 0.0% 7.87402E-06 3 K 2616
UWM ProShares Ultra Russell2000 184.1 M 1.84148E+08 2,016 2016 0.0% 1.05332E-05 4 K 4261
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.7 B 1.87292E+10 3,568 3568 0.0% 0 104 K 103840
IWC iShares Microcap ETF 916.2 M 9.16246E+08 1,452 1452 0.02% 0.0002 148 K 148307
IWM iShares Russell 2000 ETF 44.9 B 4.48577E+10 2,006 2006 0.0% 0 1.5 M 1500050
IWO iShares Russell 2000 Growth ETF 9.3 B 9.28872E+09 1,239 1239 0.01% 0.0001 506 K 505710
IWV iShares Russell 3000 ETF 9.7 B 9.71954E+09 2,931 2931 0.0% 0 34 K 33898

Wait, Before You Leave...